Addition of octreotide functional imaging to cross-sectional computed tomography or magnetic resonance imaging for the detection of neuroendocrine tumors: Added value or an anachronism? Letter uri icon

Overview

MeSH Major

  • Magnetic Resonance Imaging
  • Neuroendocrine Tumors
  • Octreotide
  • Radiopharmaceuticals
  • Tomography, Emission-Computed, Single-Photon
  • Tomography, X-Ray Computed

publication date

  • January 20, 2011

Research

keywords

  • Letter

Identity

Digital Object Identifier (DOI)

  • 10.1200/JCO.2010.32.8559

PubMed ID

  • 21079131

Additional Document Info

start page

  • e74

end page

  • 5

volume

  • 29

number

  • 3